scispace - formally typeset
W

WenYong Chen

Researcher at City of Hope National Medical Center

Publications -  16
Citations -  1435

WenYong Chen is an academic researcher from City of Hope National Medical Center. The author has contributed to research in topics: Chronic myelogenous leukemia & Imatinib. The author has an hindex of 10, co-authored 16 publications receiving 1298 citations. Previous affiliations of WenYong Chen include Beckman Research Institute.

Papers
More filters
Journal ArticleDOI

Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib

TL;DR: It is shown that the NAD(+)-dependent deacetylase SIRT1 is overexpressed in human CML LSC and Activation of p53 via Sirt1 inhibition represents a potential approach to target C ML LSC.
Journal ArticleDOI

NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response

TL;DR: It is demonstrated that in addition to modulating SIRT1 functions, the NAMPT inhibition reduces forkhead box, class ‘O’ (FOXO)3a protein expression and its downstream anti-oxidant genes catalase and manganese superoxide dismutase.
Journal ArticleDOI

Sorting out functions of sirtuins in cancer

TL;DR: The bifurcated roles of SIRT1, and perhaps several other sirtuins, in cancer may be in part a result of the nature of the genes that are involved in the cell’s genome maintenance systems.
Journal ArticleDOI

Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis

TL;DR: SIRT1 is a novel survival pathway activated by BCR-ABL expression in hematopoietic progenitor cells, which promotes oncogenic transformation and leukemogenesis and is suggested to be a therapeutic target for CML treatment to overcome resistance.